RE: Credit to the BOD is due for one thing perhaps...6 Jun 2021 10:31
I think it is worth being aware that it does happen (particularly but not exclusively on AIM). PIs get in, BODs do deals that don't really favour the PI. Not necessarily a deliberate shafting, maybe sometimes, but just because it doesn't matter sufficiently to them.
Here the situation is, I think if JM could do a non diluting deal, he could. But simply not possible for $500m capex when the companies mcap only a year or two ago was £50m. So he's trying to get the best deal he can - for existing shareholders, and obviously with half an eye on his options. If he wasn't fussed about the best deal probably could have done the deal sooner but it would have been punative to existing shareholders. I'm sure at bargain rates Orion would have parted with a lot of cash very quickly but they would have been essentially buying the company out.
I don't think we'll get shafted but it might take a medium-long (by PI timelines) timeframe to see proper return on an investment at this price. By proper of course I mean multiples - we should see an initial 1.5x on finance at least. But for people looking for crypto or covid gains here, it might be possible, but it is years down the line I feel. Araguaia will be producing in 2024 so unless people are buying for the 1.5x after finance, or for the 'what happens next with Vermelho' news, that's probably the timeframe to be thinking about investing here. All IMHO. That said still feel 7p is very good value and be very surprised if finance is done any lower. So buying tomorrow one would be buying at the placing price, or lower.